Localised Autophagy Inhibition by Nanodiamonds Potentiates Arsenic Therapy With Favourable Safety Profile in Solid Tumours
Cell Proliferation · 2026
DOI: 10.1111/cpr.70234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Yiliu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Autophagy, Antineoplastic Agents, Nanodiamonds, Liver Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Arsenic trioxide (ATO) shows limited efficacy against solid tumours, largely because it induces protective autophagy that attenuates its pro‐apoptotic activity. Our previous studies established that nanodiamonds (NDs) function as nanoparticle autophagy inhibitors (NAPIs) when delivered systemically, markedly enhancing ATO efficacy in orthotopic liver tumour models by blocking NUPR1‐mediated autolysosomal clearance. However, systemic administration remains inefficient in modulating the local autophagic microenvironment within tumours. Here we developed an interventional strategy based on intratumoral injection to assess the feasibility and biosafety of locally blocking autophagic flux while substantially reducing the required ATO dosage, thereby maximising the synergistic anti‐tumour effects of NDs and ATO. In HepG2 hepatocellular carcinoma cells, NDs markedly blocked the late stage of autophagic flux, thereby significantly amplifying ATO‐induced apoptosis. In a subcutaneous xenograft liver cancer mouse model, intratumoral co‐administration of NDs with low‐dose ATO achieved ~91% tumour inhibition and effectively eliminated the systemic toxicity associated with high‐dose ATO monotherapy. Notably, the synergistic antitumor effect was independent of increased intratumoral ATO accumulation and was driven instead by targeted modulation of the autophagic pathway. Collectively, this study demonstrates a mechanism of localised, nanomaterial‐mediated autophagy regulation and offers an efficient, safe strategy for interventional therapy of advanced solid tumours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai, China.
- Institute of Materiobiology, College of Sciences, Shanghai University, Shanghai, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.
- Department of Traumatology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Huating Kong
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- National Key Research and Development Program of China
Zitieren
APA
Wang, Y., Cui, Z., Zhang, J., Zhu, S., Guo, L., Wang, Q., Zhu, Y., Luo, S., & Kong, H. (2026). Localised Autophagy Inhibition by Nanodiamonds Potentiates Arsenic Therapy With Favourable Safety Profile in Solid Tumours. Cell Proliferation. https://doi.org/10.1111/cpr.70234
Vancouver
Wang Y, Cui Z, Zhang J, Zhu S, Guo L, Wang Q, et al. Localised Autophagy Inhibition by Nanodiamonds Potentiates Arsenic Therapy With Favourable Safety Profile in Solid Tumours. Cell Proliferation. 2026. doi:10.1111/cpr.70234
BibTeX
@article{Wang2026,
author = {Wang, Yiliu and Cui, Zhifen and Zhang, Jichao and Zhu, Shitai and Guo, Linjie and Wang, Qisheng and Zhu, Ying and Luo, Shihua and Kong, Huating},
title = {Localised Autophagy Inhibition by Nanodiamonds Potentiates Arsenic Therapy With Favourable Safety Profile in Solid Tumours},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70234}
}
EUVIMED